IP Library Assignment 058371/0661
Patent Assignment
Reel/Frame 058371/0661

Merger

Recorded: 2021-12-13 Pages: 14
Assignors
TARO PHARMACEUTICALS INC.
Executed: 2020-07-31
Assignee
TARO PHARMACEUTICALS INC.
130 EAST DRIVE, BRAMPTON, ONTARIO, L6T1C1, CANADA
Covered Properties (11)
Indene Derivatives as Pharmaceutical Agents
Patent: 7,601,874 →
Application: 10/825,084 →
Publication: US 2005/0004086
Indene Derivatives as Pharmaceutical Agents
Patent: 8,673,975 →
Application: 13/315,038 →
Publication: US 2012/0270901
SHIP1 Modulators and Methods Related Thereto
Patent: 9,765,085 →
Application: 14/772,731 →
Publication: US 2016/0031899
SHIP1 Modulators and Methods Related Thereto
Application: 14/772,737 →
Publication: US 2016/0083387
Crystalline Solid Forms of the Acetate Salt of (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(Aminomethyl)-7A-Methyl-1-Methyleneoctahydro-1H-Inden-5-Yl)-3-(Hydroxymethyl)-4-Methylcyclohexanol
Patent: 9,944,590 →
Application: 15/191,134 →
Publication: US 2016/0376222
Synthesis of a Substituted Indene Derivative
Application: 15/411,863 →
Publication: US 2017/0204048
SHIP1 Modulators and Methods Related Thereto
Application: 15/676,726 →
Publication: US 2017/0362250
Crystalline Solid Forms of the Acetate Salt of (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(Aminomethyl)-7A-Methyl-1-Methyleneoctahydro-1H-Inden-5-Yl)-3-(Hydroxymethyl)-4-Methylcyclohexanol
Application: 15/885,387 →
Publication: US 2018/0155273
Indene Derivatives Useful in Treating Pain and Inflammation
Application: 17/045,626 →
Publication: US 2021/0155615
Indene Derivatives Useful in Treating Pain and Inflammation
Application: 17/045,675 →
Publication: US 2021/0032264
Hexadecahydro-1H-Cyclopenta[A]Phenanthrene Derivatives Useful in Treating Pain and Inflammation
Application: 17/045,688 →
Publication: US 2021/0024571
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 27, 2004
From: RAYMOND, JEFFERY R.; HAN, KANG; ZHOU, YUANLIN; HE, YUEHUA
To: INFLAZYME PHARMACEUTICALS LTD.
Reel/Frame 015050/0013 →
Assignment of Assignor's Interest Sep 8, 2009
From: INFLAZYME PHARMACEUTICALS LTD.
To: BIOLIPOX AB
Reel/Frame 023196/0533 →
Assignment of Assignor's Interest Sep 9, 2009
From: BIOLIPOX AB
To: AQUINOX PHARMACEUTICALS INC.
Reel/Frame 023196/0700 →
Change of Name Oct 9, 2014
From: AQUINOX PHARMACEUTICALS INC.
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 033935/0206 →
Change of Name Oct 16, 2014
From: AQUINOX PHARMACEUTICALS INC.
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 034012/0741 →
Change of Name Sep 16, 2015
From: AQUINOX PHARMACEUTICALS INC.
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 036619/0679 →
Assignment of Assignor's Interest Sep 16, 2015
From: MACKENZIE, LLOYD F.; HARWIG, CURTIS; BOGUCKI, DAVID; RAYMOND, JEFFERY R.
To: AQUINOX PHARMACEUTICALS INC.
Reel/Frame 036581/0040 →
Change of Name Oct 15, 2015
From: AQUINOX PHARMACEUTICALS INC.
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 036874/0680 →
Assignment of Assignor's Interest Oct 15, 2015
From: MACKENZIE, LLOYD F.; MACRURY, THOMAS B.; HARWIG, CURTIS; BOGUCKI, DAVID
To: AQUINOX PHARMACEUTICALS INC.
Reel/Frame 036802/0723 →
Assignment of Assignor's Interest Aug 25, 2016
From: MACKENZIE, LLOYD F.; RAYMOND, JEFFERY R.; HARWIG, CURTIS
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 039543/0487 →
Assignment of Assignor's Interest Aug 25, 2016
From: CRYSTALLICS BV
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 039543/0601 →
Assignment of Assignor's Interest Aug 25, 2016
From: FERNANDEZ CASARES, ANA
To: CRYSTALLICS BV
Reel/Frame 039543/0557 →
Assignment of Assignor's Interest Mar 6, 2017
From: SYNGENE INTERNATIONAL LIMITED
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 041895/0502 →
Assignment of Assignor's Interest Mar 6, 2017
From: HARWIG, CURTIS
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 041895/0475 →
Assignment of Assignor's Interest Mar 6, 2017
From: SEENISAMY, JEYAPRAKASHNARAYANAN; KEREGADDE, MAHESH NARAYAN; CHETIA, LAKSHINDRA
To: SYNGENE INTERNATIONAL LIMITED
Reel/Frame 041477/0780 →
Change of Name Sep 29, 2017
From: AQUINOX PHARMACEUTICALS INC.
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 044071/0183 →
Assignment of Assignor's Interest Sep 29, 2017
From: MACKENZIE, LLOYD F.; MACRURY, THOMAS B.; HARWIG, CURTIS; BOGUCKI, DAVID
To: AQUINOX PHARMACEUTICALS INC.
Reel/Frame 043742/0829 →
Assignment of Assignor's Interest May 8, 2018
From: MACKENZIE, LLOYD F.; RAYMOND, JEFFERY R.; HARWIG, CURTIS
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 045742/0629 →
Assignment of Assignor's Interest May 8, 2018
From: CRYSTALLICS BV
To: AQUINOX PHARMACEUTICALS (CANADA) INC.
Reel/Frame 045742/0895 →
Assignment of Assignor's Interest May 8, 2018
From: FERNANDEZ CASARES, ANA
To: CRYSTALLICS BV
Reel/Frame 045742/0811 →
Assignment of Assignor's Interest Feb 22, 2022
From: HARWIG, CURTIS; PETTIGREW, JEREMY D.; CROSS, JENNIFER; SEENISAMY, JEYAPRAKASHNARAYANAN
To: TARO PHARMACEUTICALS INC.
Reel/Frame 059067/0653 →
Assignment of Assignor's Interest Feb 22, 2022
From: HARWIG, CURTIS; PETTIGREW, JEREMY D.; CROSS, JENNIFER; SEENISAMY, JEYAPRAKASHNARAYANAN
To: TARO PHARMACEUTICALS INC.
Reel/Frame 059067/0754 →
Assignment of Assignor's Interest Feb 22, 2022
From: HARWIG, CURTIS; PETTIGREW, JEREMY D.; CROSS, JENNIFER; SEENISAMY, JEYAPRAKASHNARAYANAN
To: TARO PHARMACEUTICALS INC.
Reel/Frame 059067/0486 →